The diagnosis of DADA2 is based on decreased ADA2 serum enzyme activity and the identification of two deleterious alleles in the ADA2 gene (Meyts and Aksentijevich, 2018; Jee et al., 2022). The gene discussed is ADA2; the disease is deficiency of adenosine deaminase 2.